Albertine Donker

General Introduction 41 1 and standards for ferritin concentrations. Neonatology. 2007;92(2):73-82. 70. Suzuki YA, Shin K, Lonnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry. 2001;40(51):15771-15779. 71. Yalcin SS, Baykan A, Yurdakok K, Yalcin S, Gucus AI. The factors that affect milk-to- serum ratio for iron during early lactation. Journal of pediatric hematology/oncology. 2009;31(2):85-90. 72. Domellof M, Lonnerdal B, Abrams SA, Hernell O. Iron absorption in breast-fed infants: effects of age, iron status, iron supplements, and complementary foods. The American journal of clinical nutrition. 2002;76(1):198-204. 73. Leong WI, Bowlus CL, Tallkvist J, Lonnerdal B. DMT1 and FPN1 expression during infancy: developmental regulation of iron absorption. American journal of physiology Gastrointestinal and liver physiology. 2003;285(6):G1153-1161. 74. Frazer DM, Wilkins SJ, Darshan D, Mirciov CSG, Dunn LA, Anderson GJ. Ferroportin Is Essential for Iron Absorption During Suckling, But Is Hyporesponsive to the Regulatory Hormone Hepcidin. Cellular and molecular gastroenterology and hepatology. 2017;3(3):410-421. 75. Darshan D, Wilkins SJ, Frazer DM, Anderson GJ. Reduced expression of ferroportin-1 mediates hyporesponsiveness of suckling rats to stimuli that reduce iron absorption. Gastroenterology. 2011;141(1):300-309. 76. Lind T, Seswandhana R, Persson LA, Lonnerdal B. Iron supplementation of iron- replete Indonesian infants is associated with reduced weight-for-age. Acta paediatrica (Oslo, Norway : 1992). 2008;97(6):770-775. 77. Lonnerdal B. Excess iron intake as a factor in growth, infections, and development of infants and young children. The American journal of clinical nutrition. 2017;106(Suppl 6):1681s-1687s. 78. Scott PH, Berger HM, Kenward C, Scott P, Wharton BA. Effect of gestational age and intrauterine nutrition on plasma transferrin and iron in the newborn. Arch Dis Child. 1975;50(10):796-798. 79. Fryer AA, Jones P, Strange R, Hume R, Bell JE. Plasma protein levels in normal human fetuses: 13 to 41 weeks’ gestation. British journal of obstetrics and gynaecology. 1993;100(9):850-855. 80. Collard KJ. Iron homeostasis in the neonate. Pediatrics. 2009;123(4):1208-1216. 81. Domellof M. Iron requirements, absorption and metabolism in infancy and childhood. Curr Opin Clin Nutr Metab Care. 2007;10(3):329- 335. 82. Melmed. Williams Textbook of Endocrinology. 13 ed2016. 83. Veldhuis JD, Roemmich JN, Richmond EJ, et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocrine reviews. 2005;26(1):114-146. 84. Troutt JS, Rudling M, Persson L, et al. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration. Clinical chemistry. 2012;58(8):1225-1232. 85. Lehtihet M, Bonde Y, Beckman L, et al. Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans. PloS one. 2016;11(2):e0148802. 86. Bachman E, Feng R, Travison T, et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab. 2010;95(10):4743-4747. 87. Michels K, Nemeth E, Ganz T, Mehrad B. Hepcidin and Host Defense against Infectious Diseases. PLoS pathogens. 2015;11(8):e1004998. 88. Ganz T. Iron and infection. International journal of hematology. 2017. 89. Burte F, Brown BJ, Orimadegun AE, et al. Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria. Blood. 2013;121(15):3016-3022.